NSMCE1

NSMCE1 is a subunit of the SMC5/6 genome-integrity complex that, together with NSMCE3, forms a subcomplex with antiviral activity against hepatitis B virus (PMID:41825673). The purified NSMCE1/NSMCE3 subcomplex is sufficient to inhibit HBV transcription in a cell-free reporter assay, acting independently of the full holo-complex (PMID:41825673). NSMCE1/NSMCE3 additionally drives degradation of the viral HBx protein through a ubiquitin-independent route: degradation requires proteasome activity but not E1 ubiquitin-activating enzyme function, and the subcomplex physically associates with the 20S proteasome without stimulating HBx ubiquitination (PMID:41825673). Through these combined transcriptional and post-translational effects, NSMCE1/NSMCE3 represses HBx at the mRNA and protein level and restricts HBV proliferation in hepatoma cells, whereas NSMCE3 knockdown enhances viral proliferation (PMID:41825673). In mouse hippocampal neuronal cells, Nsmce1 modulates expression of Alzheimer's disease marker genes and reshapes alternative splicing toward the ubiquitin-mediated proteolysis pathway (PMID:31792732). Beyond these findings, the molecular basis of NSMCE1's contribution to the intact SMC5/6 complex has not been characterized in the available corpus.

1. 2019 Low

   Established the first cellular phenotype for NSMCE1 outside canonical genome maintenance, linking it to neuronal gene-expression control and splicing regulation.

   Evidence Overexpression and knockdown in HT-22 hippocampal cells with marker-gene qPCR, proliferation assays, and RNA-seq

   PMID:31792732

   Open questions at the time

   • No direct molecular mechanism or pathway placement for the splicing/proteolysis effects
   • AD marker-gene changes are correlative, not mechanistically connected to NSMCE1 activity
   • Single lab, single cell line
2. 2026 Medium

   Showed that the NSMCE1/NSMCE3 subcomplex alone is sufficient to repress HBV transcription, decoupling this antiviral function from the full SMC5/6 holo-complex.

   Evidence Cell-free transcription assay with purified NSMCE1/3 subcomplex and luciferase reporter

   PMID:41825673

   Open questions at the time

   • In vitro reconstitution only; not validated in chromatinized cellular HBV context
   • Mechanism of transcriptional repression unresolved
   • Single study, single lab
3. 2026 Medium

   Defined a ubiquitin-independent proteasomal pathway by which NSMCE1/NSMCE3 degrades the viral HBx protein and restricts HBV proliferation.

   Evidence Cycloheximide chase, proteasome and E1 inhibitor treatments, 20S proteasome Co-IP and ubiquitination assays, plus gain/loss-of-function in hepatoma cells

   PMID:41825673

   Open questions at the time

   • Structural basis of NSMCE1/3 binding to the 20S proteasome unknown
   • How HBx is targeted to the proteasome without ubiquitination is unresolved
   • Reciprocal validation of the 20S interaction not described

• How NSMCE1's antiviral and proteasome-directing activities relate to its role within the intact SMC5/6 complex and to genome integrity remains unresolved.
• No structural or biochemical characterization of NSMCE1 within full SMC5/6 in this corpus
• Connection between neuronal splicing/proteolysis role and antiviral role unestablished
• No in vivo evidence for the antiviral mechanism